cardiovascular system
|
• 15% of E11.5 embryos and 29% by E15.5 exhibit fourth-related arch artery defects
|
|
• 17% of embryos exhibit a ventricular septum defect, of which one has an overriding aorta
|
craniofacial
|
• 15% of E11.5 embryos and 29% by E15.5 exhibit fourth-related arch artery defects
|
cleft palate
(
J:212881
)
|
• 12.5% of embryos exhibit a cleft palate
|
digestive/alimentary system
cleft palate
(
J:212881
)
|
• 12.5% of embryos exhibit a cleft palate
|
embryo
|
• 15% of E11.5 embryos and 29% by E15.5 exhibit fourth-related arch artery defects
|
endocrine/exocrine glands
|
• 92% of embryos exhibit a thymus defect, ranging from mildly hypoplastic, hypoplastic, aplastic, or single lobe phenotypes
|
growth/size/body
cleft palate
(
J:212881
)
|
• 12.5% of embryos exhibit a cleft palate
|
hematopoietic system
|
• 92% of embryos exhibit a thymus defect, ranging from mildly hypoplastic, hypoplastic, aplastic, or single lobe phenotypes
|
immune system
|
• 92% of embryos exhibit a thymus defect, ranging from mildly hypoplastic, hypoplastic, aplastic, or single lobe phenotypes
|


Analysis Tools